OTCM
GRGBF
Market cap8mUSD
, Last price
USD
Name
Greenrise Global Brands Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
35.83%
Rev. gr., 5y
-68.38%
Revenues
0k
Net income
0k
P
CFO
199k
P
Profile
Greenrise Global Brands Inc., through its subsidiaries, operates as a pharmaceutical supplier of medical cannabis products to pharmacies in Germany. It offers a range of CBD products consisting of tinctures, sprays, oils, and skincare products through drugstores; and imports and sells EU-GMP medical and cosmetic cannabis products. The company was formerly known as AMP Alternative Medical Products Inc. and changed its name to Greenrise Global Brands Inc. in November 2021. Greenrise Global Brands Inc. is based in Vancouver, Canada.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | 391 | 561 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (391) | (561) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (361) | 871 | |||||||
Tax Rate | |||||||||
NOPAT | (30) | (1,432) | |||||||
Net income | (2,316) -38.71% | ||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 832 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 180 | 640 | |||||||
Long-term debt | 2,620 | 2,508 | |||||||
Deferred revenue | 5,150 | ||||||||
Other long-term liabilities | (1,241) | ||||||||
Net debt | 2,769 | 3,768 | |||||||
| Cash flow | |||||||||
Cash from operating activities | 199 | (1,075) | |||||||
CAPEX | |||||||||
Cash from investing activities | 388 | (531) | |||||||
Cash from financing activities | (535) | 1,507 | |||||||
FCF | 996 | (2,714) | |||||||
| Balance | |||||||||
Cash | 32 | (620) | |||||||
Long term investments | |||||||||
Excess cash | 32 | ||||||||
Stockholders' equity | (1,318) | (499) | |||||||
Invested Capital | 1,504 | 5,241 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 47,236 | 38,594 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (391) | (561) | |||||||
EV/EBITDA | |||||||||
Interest | 137 | ||||||||
Interest/NOPBT | |||||||||